Results 31 to 40 of about 696,855 (303)

Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular restoring effects in myocardial fibrosis therapy

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Myocardial fibrosis is the result of abnormal healing after acute and chronic myocardial damage and is a direct cause of heart failure and cardiac insufficiency.
Tian Yue   +13 more
doaj   +1 more source

Magnetic resonance imaging as a non-invasive tool to investigate pulmonary and renal fibrosis in small rodents : method and readout validation, animal model optimization, and substance testing [PDF]

open access: yes, 2015
Pulmonary fibrosis, an end result of various types of lung damage including interstitial pneumonia and respiratory bronchiolitis (Gross and Hunninghake, 2001; Katzenstein and Myers, 1998; Lazenby et al., 1990) is a lethal disease characterized by ...
Egger, Christine
core   +1 more source

Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy

open access: yesCardiovascular Innovations and Applications, 2021
Hypertrophic cardiomyopathy (HCM) is a type of hereditary cardiomyopathy caused by gene mutation. Its histological features include cardiomyocyte hypertrophy and disarray as well as myocardial fibrosis.
Zeyi Cheng   +3 more
doaj   +1 more source

DIAGNOSTIC METHODS FOR MYOCARDIAL FIBROSIS

open access: yesИзмерение, мониторинг, управление, контроль, 2023
Background. Myocardial fibrosis is a global public health problem because it is associated with almost all forms of cardiovascular diseases. Timely detection of myocardial fibrosis is an urgent task contributing to improving the quality of patients' life
Natalia A. Serzhantova
doaj   +1 more source

Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway

open access: yesFrontiers in Pharmacology, 2021
Background: Lcz696 (ARNI, angiotensin receptor–neprilysin inhibitor; sacubitril/valsartan) shows an inhibitory effect on fibrosis after myocardial infarction (MI). However, the underlying signaling mechanisms are poorly understood.
Jing Liu   +5 more
doaj   +1 more source

Myocardial fibrosis in athletes—Current perspective [PDF]

open access: yesClinical Cardiology, 2020
AbstractSeveral previous studies suggested that prolonged and extensive physical activity might lead to increased prevalence of myocardial fibrosis in athletes. The review summarizes these studies focusing on common patterns of myocardial fibrosis observed in athletes, their potential causes and significance.
Łukasz A. Małek   +1 more
openaire   +3 more sources

T1 Mapping for Myocardial Fibrosis by Cardiac Magnetic Resonance Relaxometry—A Comprehensive Technical Review [PDF]

open access: yes, 2017
Cardiac magnetic resonance (CMR) imaging has been widely used to assess myocardial perfusion and scar and is the non-invasive gold standard for identification of focal myocardial fibrosis.
Hamilton-Craig, Christian R.   +8 more
core   +1 more source

The Prognostic Role of the Left Atrium in Hypertensive Patients with HFpEF: Does Function Matter More than Structure?

open access: yesLife
Background: In arterial hypertension (AH), adverse hemodynamic consequences in the left atrium (LA) are often observed. The prognostic significance of functional vs.
Artem Ovchinnikov   +6 more
doaj   +1 more source

EGCG Alleviates Obesity-Induced Myocardial Fibrosis in Rats by Enhancing Expression of SCN5A

open access: yesFrontiers in Cardiovascular Medicine, 2022
ObjectObesity is an increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Obesity could increase the risk of myocardial fibrosis. (-)-Epigallocatechin-3-gallate (
Haoan Yi   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy